Bis(4-(di-tert-Butylphosphanyl)-N,N-dimethylaniline)-palladium chloride, 98.0%, 1g

1-Benzyl-4-bromo-1,2,3,6-tetrahydropyridine, 95.0%, 250mg

Diisopropyl ether, min. 98%, for synthesis, stab., 25 l, whitbl.

4-Chloro-3-[(dimethylamino)methyl]aniline, 95%, 50mg

4-Amino-2,6-difluorobenzonitrile, 95.0%, 1g

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1H-pyrrolo[2,3-b]pyridine, 95.0%, 1g

(4R,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-4-methyl-1,3-oxazolidin-2-one, 98%, 1g

4,6-DICHLORO-1H-INDAZOLE, 95%, 100mg

2-(Piperidin-4-yl)pyridine dihydrochloride, 98+%, 1g

3-aminobicyclo[1.1.1]pentan-1-ol hydrochloride, 95.0%, 1g

Narrow mouth bottle 301, 500 ml, 25 mm, 10 Piece(s)

3-Bromo-5-methoxy-1-methyl-1H-indazole, 98%, 250mg

1-(4-Methoxybenzyl)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 95.0%, 1g